Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction 
Parexel and Kyoto University Hospital Announce Strategic Alliance
Ki-CONNECT collaboration seeks to offer clinical trial benefits to patients and the pharmaceutical industryBOSTON and DURHAM, N.C., Oct. 20, 2021...
Clinical Data from Editas Medicine’s Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 to be Presented at the European Society of Gene and Cell Therapy Annual Congress
CAMBRIDGE, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that...
AXIM Biotechnologies Appoints Dry Eye Disease Expert and Accomplished Optometrist Dr. Kelly K. Nichols to its Medical Advisory Board
Dr. Nichols Strengthens Board with 25 Years of Optometry and Academic ExperienceSAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- AXIM...
eSight Announces Clinical Research Partnership with Ocular Health Centre’s EyeStart Inc.
Collaboration with EyeStart to help develop the next generation of eSight devicesTORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement...
Allied Corp Signs Major Supply Agreement With US Multi State Operator (MSO) and Sales Agreement for Allied’s CBD Brands
KELOWNA, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Voyager Therapeutics Presents Positive Preclinical Data Supporting CNS-Directed GBA1 Gene Therapy at Virtual Congress of the European Society of Gene and Cell Therapy
Single AAV intravenous dose achieved widespread CNS distribution and sustained correction of GCase activity in multiple brain regionsCAMBRIDGE, Mass., Oct....
Pure Extracts Ships Repeat Orders of Edible Gummies and Vapes
VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Simply Better Brands Corp. Positioning for Significant Growth Fueled by Customer Acquisition, New Distribution and Geographic Expansion
VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. ("SBBC" or the "Company") (TSX Venture: SBBC)...
Healthy Extracts Launches High-Potency Organic Citrus Bergamot Formulations with Clinically Proven Heart Benefits, Available Exclusively on Amazon
Organic Citrus Bergamot for Women Organic Citrus Bergamot for Women LAS VEGAS, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Healthy Extracts...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision...
OliX Pharmaceuticals Enters Agreement with Pharmaron to Advance Non-clinical Toxicology Testing for Hepatitis B Candidate OLX703A
Previous non-clinical pharmacology study demonstrated substantial reduction in serum markers of HBVSUWON, Republic of Korea, Oct. 20, 2021 (GLOBE NEWSWIRE)...
Sensus Healthcare to Host Third Quarter 2021 Financial Results and Business Update Conference Call on November 4, 2021
BOCA RATON, Fla, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in...
Homology Medicines Announces Presentation of Data Supporting Clinical Programs in MPS II and PKU, including Nonclinical and Patient-Focused Research, at American Society of Human Genetics Meeting
- Oral Presentation on In Vivo Gene Therapy Product Candidate and Data on Gene Editing Candidate Paved Way for Initiation...
CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI
BERKELEY HEIGHTS, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer
Study met both primary endpoints in patients with ER+/HER2- advanced or mBCElacestrant becomes the first oral SERD with positive topline...
Longeveron Announces Activation of Two New Clinical Sites in ELPIS II Trial of Lomecel-B for Hypoplastic Left Heart Syndrome (HLHS)
MIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular...
Evoke Pharma and EVERSANA Announce Positive Findings from GIMOTI® Market Research Study
Evoke Pharma, Inc. Trend Across Waves for Proportion of Respondents Who Are Highly Familiar With GIMOTI (score of 4 or...
Maple Leaf Green World Inc. Unveils New CBG Wellness Brand
CALGARY, Alberta, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”), (CSE: MGW)...
Halberd’s PTSD/Alzheimer’s R&D Reveals Link to Potential Obesity Cure
Jackson Center, Pennsylvania--(Newsfile Corp. - October 20, 2021) - Halberd Corporation's (OTC Pink: HALB) ongoing research into discovering treatments/cures for...
Awakn Life Sciences Bristol Clinic Receives Care Quality Commission Approval to Begin Treatments in the UK’s First Medical Psychedelic Clinic
The clinic will begin delivering ketamine-assisted psychotherapy treatments in OctoberToronto, Ontario--(Newsfile Corp. - October 20, 2021) - Awakn Life Sciences...